nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CYP3A4—bone cancer	0.624	1	CbGaD
Indapamide—KCNE1—TarBasePathway—ERG—bone cancer	0.1	0.626	CbGpPWpGaD
Indapamide—KCNQ1—TarBasePathway—ERG—bone cancer	0.0302	0.189	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00579	0.0362	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00532	0.0333	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000955	0.00597	CbGpPWpGaD
Indapamide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000898	0.00562	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—BMI1—bone cancer	0.000784	0.00491	CbGpPWpGaD
Indapamide—Bumetanide—PTGS2—bone cancer	0.000747	0.552	CrCbGaD
Indapamide—Oxcarbazepine—CYP3A4—bone cancer	0.000606	0.448	CrCbGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000538	0.00337	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NDUFA12—bone cancer	0.000526	0.00329	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000516	0.00323	CbGpPWpGaD
Indapamide—CA7—Metabolism—NDUFA12—bone cancer	0.000491	0.00307	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NDUFA12—bone cancer	0.000491	0.00307	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000465	0.00291	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—JUN—bone cancer	0.000458	0.00286	CbGpPWpGaD
Indapamide—CA12—Metabolism—NDUFA12—bone cancer	0.000455	0.00285	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NT5C3A—bone cancer	0.000436	0.00273	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000421	0.00263	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000411	0.00257	CbGpPWpGaD
Indapamide—CA7—Metabolism—NT5C3A—bone cancer	0.000407	0.00255	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NT5C3A—bone cancer	0.000407	0.00255	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—BRAF—bone cancer	0.000395	0.00247	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—EZH2—bone cancer	0.000381	0.00239	CbGpPWpGaD
Indapamide—CA12—Metabolism—NT5C3A—bone cancer	0.000377	0.00236	CbGpPWpGaD
Indapamide—CA4—Metabolism—NDUFA12—bone cancer	0.000363	0.00227	CbGpPWpGaD
Indapamide—CA2—Metabolism—NDUFA12—bone cancer	0.000348	0.00218	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—MDM2—bone cancer	0.000331	0.00207	CbGpPWpGaD
Indapamide—Angina pectoris—Doxorubicin—bone cancer	0.000316	0.00148	CcSEcCtD
Indapamide—Hepatobiliary disease—Methotrexate—bone cancer	0.000316	0.00147	CcSEcCtD
Indapamide—Pneumonia—Epirubicin—bone cancer	0.000315	0.00147	CcSEcCtD
Indapamide—Drowsiness—Epirubicin—bone cancer	0.000313	0.00146	CcSEcCtD
Indapamide—Bronchitis—Doxorubicin—bone cancer	0.000312	0.00146	CcSEcCtD
Indapamide—Agranulocytosis—Methotrexate—bone cancer	0.000312	0.00146	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00031	0.00145	CcSEcCtD
Indapamide—Renal failure—Epirubicin—bone cancer	0.000308	0.00143	CcSEcCtD
Indapamide—Body temperature increased—Cisplatin—bone cancer	0.000307	0.00143	CcSEcCtD
Indapamide—Jaundice—Epirubicin—bone cancer	0.000305	0.00142	CcSEcCtD
Indapamide—Stomatitis—Epirubicin—bone cancer	0.000305	0.00142	CcSEcCtD
Indapamide—Conjunctivitis—Epirubicin—bone cancer	0.000304	0.00142	CcSEcCtD
Indapamide—Urinary tract infection—Epirubicin—bone cancer	0.000304	0.00142	CcSEcCtD
Indapamide—Dysuria—Doxorubicin—bone cancer	0.000304	0.00142	CcSEcCtD
Indapamide—CA4—Metabolism—NT5C3A—bone cancer	0.000301	0.00188	CbGpPWpGaD
Indapamide—Hepatitis—Methotrexate—bone cancer	0.0003	0.0014	CcSEcCtD
Indapamide—Sweating—Epirubicin—bone cancer	0.0003	0.0014	CcSEcCtD
Indapamide—Pollakiuria—Doxorubicin—bone cancer	0.0003	0.0014	CcSEcCtD
Indapamide—Pharyngitis—Methotrexate—bone cancer	0.000298	0.00139	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—GSTP1—bone cancer	0.000297	0.00186	CbGpPWpGaD
Indapamide—Urinary tract disorder—Methotrexate—bone cancer	0.000297	0.00138	CcSEcCtD
Indapamide—Photosensitivity reaction—Doxorubicin—bone cancer	0.000297	0.00138	CcSEcCtD
Indapamide—Hepatobiliary disease—Epirubicin—bone cancer	0.000296	0.00138	CcSEcCtD
Indapamide—Urethral disorder—Methotrexate—bone cancer	0.000294	0.00137	CcSEcCtD
Indapamide—Weight decreased—Doxorubicin—bone cancer	0.000294	0.00137	CcSEcCtD
Indapamide—Sinusitis—Epirubicin—bone cancer	0.000294	0.00137	CcSEcCtD
Indapamide—CA9—Metabolism—NDUFA12—bone cancer	0.000293	0.00183	CbGpPWpGaD
Indapamide—Hyperglycaemia—Doxorubicin—bone cancer	0.000293	0.00137	CcSEcCtD
Indapamide—Agranulocytosis—Epirubicin—bone cancer	0.000292	0.00136	CcSEcCtD
Indapamide—Pneumonia—Doxorubicin—bone cancer	0.000291	0.00136	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—bone cancer	0.00029	0.00135	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—bone cancer	0.000289	0.00135	CcSEcCtD
Indapamide—CA2—Metabolism—NT5C3A—bone cancer	0.000288	0.0018	CbGpPWpGaD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000287	0.00134	CcSEcCtD
Indapamide—Hypersensitivity—Cisplatin—bone cancer	0.000286	0.00134	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—bone cancer	0.000285	0.00133	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—bone cancer	0.000284	0.00132	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—bone cancer	0.000282	0.00132	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—bone cancer	0.000282	0.00132	CcSEcCtD
Indapamide—Rhinitis—Epirubicin—bone cancer	0.000282	0.00131	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—bone cancer	0.000282	0.00131	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—bone cancer	0.000282	0.00131	CcSEcCtD
Indapamide—Hepatitis—Epirubicin—bone cancer	0.000281	0.00131	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—bone cancer	0.00028	0.00131	CcSEcCtD
Indapamide—Hypoaesthesia—Epirubicin—bone cancer	0.00028	0.0013	CcSEcCtD
Indapamide—Asthenia—Cisplatin—bone cancer	0.000279	0.0013	CcSEcCtD
Indapamide—Pharyngitis—Epirubicin—bone cancer	0.000279	0.0013	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—bone cancer	0.000279	0.0013	CcSEcCtD
Indapamide—Sweating—Doxorubicin—bone cancer	0.000278	0.00129	CcSEcCtD
Indapamide—Urinary tract disorder—Epirubicin—bone cancer	0.000278	0.00129	CcSEcCtD
Indapamide—Oedema peripheral—Epirubicin—bone cancer	0.000277	0.00129	CcSEcCtD
Indapamide—Urethral disorder—Epirubicin—bone cancer	0.000275	0.00128	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—bone cancer	0.000274	0.00128	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—bone cancer	0.000272	0.00127	CcSEcCtD
Indapamide—Visual impairment—Epirubicin—bone cancer	0.000271	0.00126	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—bone cancer	0.00027	0.00126	CcSEcCtD
Indapamide—Diarrhoea—Cisplatin—bone cancer	0.000266	0.00124	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—bone cancer	0.000266	0.00124	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—bone cancer	0.000262	0.00122	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—bone cancer	0.000261	0.00122	CcSEcCtD
Indapamide—Erythema—Methotrexate—bone cancer	0.000261	0.00122	CcSEcCtD
Indapamide—Flushing—Epirubicin—bone cancer	0.000261	0.00122	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—bone cancer	0.000261	0.00122	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—bone cancer	0.000261	0.00122	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—bone cancer	0.00026	0.00121	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—bone cancer	0.000259	0.00121	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—bone cancer	0.000258	0.0012	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—bone cancer	0.000257	0.0012	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—bone cancer	0.000256	0.00119	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—bone cancer	0.000256	0.00119	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—bone cancer	0.000255	0.00119	CcSEcCtD
Indapamide—Back pain—Methotrexate—bone cancer	0.000253	0.00118	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—bone cancer	0.000251	0.00117	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—bone cancer	0.000251	0.00117	CcSEcCtD
Indapamide—Vomiting—Cisplatin—bone cancer	0.000247	0.00115	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—bone cancer	0.000246	0.00115	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—bone cancer	0.000246	0.00115	CcSEcCtD
Indapamide—Rash—Cisplatin—bone cancer	0.000245	0.00114	CcSEcCtD
Indapamide—Dermatitis—Cisplatin—bone cancer	0.000245	0.00114	CcSEcCtD
Indapamide—Erythema—Epirubicin—bone cancer	0.000245	0.00114	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—bone cancer	0.000245	0.00114	CcSEcCtD
Indapamide—CA9—Metabolism—NT5C3A—bone cancer	0.000243	0.00152	CbGpPWpGaD
Indapamide—Ill-defined disorder—Methotrexate—bone cancer	0.000243	0.00113	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—bone cancer	0.000242	0.00113	CcSEcCtD
Indapamide—Anaemia—Methotrexate—bone cancer	0.000242	0.00113	CcSEcCtD
Indapamide—Flushing—Doxorubicin—bone cancer	0.000241	0.00113	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—bone cancer	0.000241	0.00113	CcSEcCtD
Indapamide—Flatulence—Epirubicin—bone cancer	0.000241	0.00112	CcSEcCtD
Indapamide—Tension—Epirubicin—bone cancer	0.00024	0.00112	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—bone cancer	0.00024	0.00112	CcSEcCtD
Indapamide—Nervousness—Epirubicin—bone cancer	0.000238	0.00111	CcSEcCtD
Indapamide—Back pain—Epirubicin—bone cancer	0.000237	0.0011	CcSEcCtD
Indapamide—Malaise—Methotrexate—bone cancer	0.000236	0.0011	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—bone cancer	0.000235	0.0011	CcSEcCtD
Indapamide—Vertigo—Methotrexate—bone cancer	0.000235	0.00109	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—bone cancer	0.000234	0.00109	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—bone cancer	0.000232	0.00108	CcSEcCtD
Indapamide—Nausea—Cisplatin—bone cancer	0.000231	0.00108	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—bone cancer	0.000231	0.00107	CcSEcCtD
Indapamide—Cough—Methotrexate—bone cancer	0.000228	0.00106	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—bone cancer	0.000227	0.00106	CcSEcCtD
Indapamide—Erythema—Doxorubicin—bone cancer	0.000226	0.00106	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—bone cancer	0.000226	0.00106	CcSEcCtD
Indapamide—Anaemia—Epirubicin—bone cancer	0.000226	0.00105	CcSEcCtD
Indapamide—Agitation—Epirubicin—bone cancer	0.000225	0.00105	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—bone cancer	0.000223	0.00104	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—bone cancer	0.000223	0.00104	CcSEcCtD
Indapamide—Myalgia—Methotrexate—bone cancer	0.000223	0.00104	CcSEcCtD
Indapamide—Chest pain—Methotrexate—bone cancer	0.000223	0.00104	CcSEcCtD
Indapamide—Tension—Doxorubicin—bone cancer	0.000222	0.00104	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—bone cancer	0.000222	0.00103	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000221	0.00103	CcSEcCtD
Indapamide—Malaise—Epirubicin—bone cancer	0.000221	0.00103	CcSEcCtD
Indapamide—Discomfort—Methotrexate—bone cancer	0.00022	0.00103	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—bone cancer	0.00022	0.00102	CcSEcCtD
Indapamide—Vertigo—Epirubicin—bone cancer	0.00022	0.00102	CcSEcCtD
Indapamide—Syncope—Epirubicin—bone cancer	0.000219	0.00102	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—bone cancer	0.000219	0.00102	CcSEcCtD
Indapamide—Back pain—Doxorubicin—bone cancer	0.000219	0.00102	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—bone cancer	0.000218	0.00101	CcSEcCtD
Indapamide—Palpitations—Epirubicin—bone cancer	0.000216	0.00101	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CDK4—bone cancer	0.000215	0.00135	CbGpPWpGaD
Indapamide—Loss of consciousness—Epirubicin—bone cancer	0.000215	0.001	CcSEcCtD
Indapamide—Cough—Epirubicin—bone cancer	0.000213	0.000995	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—bone cancer	0.000213	0.000995	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—bone cancer	0.000213	0.000995	CcSEcCtD
Indapamide—Infection—Methotrexate—bone cancer	0.000212	0.000988	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—bone cancer	0.00021	0.000979	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—bone cancer	0.000209	0.000975	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—bone cancer	0.000209	0.000975	CcSEcCtD
Indapamide—Thrombocytopenia—Methotrexate—bone cancer	0.000209	0.000974	CcSEcCtD
Indapamide—Myalgia—Epirubicin—bone cancer	0.000208	0.000971	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—bone cancer	0.000208	0.000971	CcSEcCtD
Indapamide—Chest pain—Epirubicin—bone cancer	0.000208	0.000971	CcSEcCtD
Indapamide—Agitation—Doxorubicin—bone cancer	0.000208	0.00097	CcSEcCtD
Indapamide—Anxiety—Epirubicin—bone cancer	0.000208	0.000968	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—bone cancer	0.000207	0.000966	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000207	0.000964	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—bone cancer	0.000206	0.000962	CcSEcCtD
Indapamide—Discomfort—Epirubicin—bone cancer	0.000206	0.000959	CcSEcCtD
Indapamide—Malaise—Doxorubicin—bone cancer	0.000204	0.000952	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—bone cancer	0.000204	0.00095	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—bone cancer	0.000203	0.000948	CcSEcCtD
Indapamide—Anorexia—Methotrexate—bone cancer	0.000203	0.000948	CcSEcCtD
Indapamide—Syncope—Doxorubicin—bone cancer	0.000203	0.000946	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—bone cancer	0.000203	0.000945	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—bone cancer	0.0002	0.000933	CcSEcCtD
Indapamide—Oedema—Epirubicin—bone cancer	0.0002	0.000931	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—bone cancer	0.0002	0.000931	CcSEcCtD
Indapamide—Hypotension—Methotrexate—bone cancer	0.000199	0.000929	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—bone cancer	0.000199	0.000927	CcSEcCtD
Indapamide—Infection—Epirubicin—bone cancer	0.000198	0.000925	CcSEcCtD
Indapamide—Cough—Doxorubicin—bone cancer	0.000198	0.000921	CcSEcCtD
Indapamide—Shock—Epirubicin—bone cancer	0.000196	0.000916	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—bone cancer	0.000196	0.000913	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—bone cancer	0.000195	0.000911	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—bone cancer	0.000195	0.000908	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000194	0.000906	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—bone cancer	0.000194	0.000904	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—bone cancer	0.000193	0.0009	CcSEcCtD
Indapamide—Insomnia—Methotrexate—bone cancer	0.000193	0.0009	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—bone cancer	0.000193	0.000898	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—bone cancer	0.000193	0.000898	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—bone cancer	0.000193	0.000898	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—bone cancer	0.000192	0.000895	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—bone cancer	0.000192	0.000893	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000191	0.000892	CcSEcCtD
Indapamide—CA5A—Metabolism—ENO2—bone cancer	0.000191	0.00119	CbGpPWpGaD
Indapamide—Discomfort—Doxorubicin—bone cancer	0.00019	0.000888	CcSEcCtD
Indapamide—Anorexia—Epirubicin—bone cancer	0.00019	0.000887	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—bone cancer	0.00019	0.000887	CcSEcCtD
Indapamide—Somnolence—Methotrexate—bone cancer	0.00019	0.000884	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—bone cancer	0.000188	0.000879	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—bone cancer	0.000188	0.000876	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—RB1—bone cancer	0.000187	0.00117	CbGpPWpGaD
Indapamide—Hypotension—Epirubicin—bone cancer	0.000187	0.00087	CcSEcCtD
Indapamide—Decreased appetite—Methotrexate—bone cancer	0.000185	0.000865	CcSEcCtD
Indapamide—Oedema—Doxorubicin—bone cancer	0.000185	0.000861	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—bone cancer	0.000185	0.000861	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000184	0.000859	CcSEcCtD
Indapamide—Fatigue—Methotrexate—bone cancer	0.000184	0.000858	CcSEcCtD
Indapamide—Infection—Doxorubicin—bone cancer	0.000184	0.000856	CcSEcCtD
Indapamide—Pain—Methotrexate—bone cancer	0.000182	0.000851	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000182	0.000848	CcSEcCtD
Indapamide—Shock—Doxorubicin—bone cancer	0.000182	0.000847	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—bone cancer	0.000181	0.000845	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—bone cancer	0.000181	0.000843	CcSEcCtD
Indapamide—Insomnia—Epirubicin—bone cancer	0.000181	0.000842	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—bone cancer	0.00018	0.000841	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—bone cancer	0.000179	0.000837	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—bone cancer	0.000179	0.000836	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—bone cancer	0.000179	0.000833	CcSEcCtD
Indapamide—CA5B—Metabolism—ENO2—bone cancer	0.000178	0.00112	CbGpPWpGaD
Indapamide—CA7—Metabolism—ENO2—bone cancer	0.000178	0.00112	CbGpPWpGaD
Indapamide—Dyspnoea—Epirubicin—bone cancer	0.000178	0.00083	CcSEcCtD
Indapamide—Somnolence—Epirubicin—bone cancer	0.000177	0.000827	CcSEcCtD
Indapamide—CA5A—Metabolism—DHFR—bone cancer	0.000177	0.00111	CbGpPWpGaD
Indapamide—Anorexia—Doxorubicin—bone cancer	0.000176	0.000821	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—bone cancer	0.000176	0.00082	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—bone cancer	0.000176	0.000819	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—bone cancer	0.000174	0.000813	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—bone cancer	0.000174	0.000809	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—bone cancer	0.000173	0.000805	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000172	0.000804	CcSEcCtD
Indapamide—Fatigue—Epirubicin—bone cancer	0.000172	0.000802	CcSEcCtD
Indapamide—Constipation—Epirubicin—bone cancer	0.000171	0.000796	CcSEcCtD
Indapamide—Pain—Epirubicin—bone cancer	0.000171	0.000796	CcSEcCtD
Indapamide—Urticaria—Methotrexate—bone cancer	0.000169	0.00079	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—bone cancer	0.000169	0.000786	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—bone cancer	0.000169	0.000786	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000168	0.000785	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—bone cancer	0.000167	0.000779	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—bone cancer	0.000166	0.000773	CcSEcCtD
Indapamide—CA5A—Metabolism—GNA11—bone cancer	0.000166	0.00104	CbGpPWpGaD
Indapamide—CA5B—Metabolism—DHFR—bone cancer	0.000165	0.00103	CbGpPWpGaD
Indapamide—CA7—Metabolism—DHFR—bone cancer	0.000165	0.00103	CbGpPWpGaD
Indapamide—CA12—Metabolism—ENO2—bone cancer	0.000165	0.00103	CbGpPWpGaD
Indapamide—Dyspnoea—Doxorubicin—bone cancer	0.000165	0.000768	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—bone cancer	0.000165	0.000767	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—bone cancer	0.000164	0.000766	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—bone cancer	0.000163	0.000761	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—bone cancer	0.000163	0.000758	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—bone cancer	0.000161	0.000749	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—MDM2—bone cancer	0.00016	0.000999	CbGpPWpGaD
Indapamide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000159	0.000744	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—bone cancer	0.000159	0.000743	CcSEcCtD
Indapamide—Urticaria—Epirubicin—bone cancer	0.000159	0.000739	CcSEcCtD
Indapamide—Constipation—Doxorubicin—bone cancer	0.000158	0.000736	CcSEcCtD
Indapamide—Pain—Doxorubicin—bone cancer	0.000158	0.000736	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—bone cancer	0.000158	0.000736	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—bone cancer	0.000158	0.000736	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—bone cancer	0.000157	0.000733	CcSEcCtD
Indapamide—CA5B—Metabolism—GNA11—bone cancer	0.000155	0.000967	CbGpPWpGaD
Indapamide—CA7—Metabolism—GNA11—bone cancer	0.000155	0.000967	CbGpPWpGaD
Indapamide—CA12—Metabolism—DHFR—bone cancer	0.000153	0.000959	CbGpPWpGaD
Indapamide—Asthenia—Methotrexate—bone cancer	0.000153	0.000714	CcSEcCtD
Indapamide—Feeling abnormal—Doxorubicin—bone cancer	0.000152	0.00071	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000151	0.000704	CcSEcCtD
Indapamide—Pruritus—Methotrexate—bone cancer	0.000151	0.000704	CcSEcCtD
Indapamide—CA5A—Metabolism—CYP3A4—bone cancer	0.00015	0.000939	CbGpPWpGaD
Indapamide—Hypersensitivity—Epirubicin—bone cancer	0.000147	0.000686	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—bone cancer	0.000147	0.000684	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—bone cancer	0.000146	0.000681	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—bone cancer	0.000146	0.000681	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—bone cancer	0.000146	0.000681	CcSEcCtD
Indapamide—Asthenia—Epirubicin—bone cancer	0.000143	0.000668	CcSEcCtD
Indapamide—CA12—Metabolism—GNA11—bone cancer	0.000143	0.000896	CbGpPWpGaD
Indapamide—Pruritus—Epirubicin—bone cancer	0.000141	0.000659	CcSEcCtD
Indapamide—Dizziness—Methotrexate—bone cancer	0.000141	0.000658	CcSEcCtD
Indapamide—CA7—Metabolism—CYP3A4—bone cancer	0.00014	0.000877	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP3A4—bone cancer	0.00014	0.000877	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—JUN—bone cancer	0.000139	0.000868	CbGpPWpGaD
Indapamide—Diarrhoea—Epirubicin—bone cancer	0.000137	0.000637	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—bone cancer	0.000136	0.000635	CcSEcCtD
Indapamide—Vomiting—Methotrexate—bone cancer	0.000136	0.000632	CcSEcCtD
Indapamide—Rash—Methotrexate—bone cancer	0.000135	0.000627	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—bone cancer	0.000134	0.000627	CcSEcCtD
Indapamide—Headache—Methotrexate—bone cancer	0.000134	0.000623	CcSEcCtD
Indapamide—Asthenia—Doxorubicin—bone cancer	0.000133	0.000618	CcSEcCtD
Indapamide—Dizziness—Epirubicin—bone cancer	0.000132	0.000616	CcSEcCtD
Indapamide—CA4—Metabolism—ENO2—bone cancer	0.000132	0.000824	CbGpPWpGaD
Indapamide—Pruritus—Doxorubicin—bone cancer	0.000131	0.000609	CcSEcCtD
Indapamide—CA12—Metabolism—CYP3A4—bone cancer	0.00013	0.000812	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTP1—bone cancer	0.000128	0.000803	CbGpPWpGaD
Indapamide—Vomiting—Epirubicin—bone cancer	0.000127	0.000592	CcSEcCtD
Indapamide—Nausea—Methotrexate—bone cancer	0.000127	0.000591	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—bone cancer	0.000126	0.000589	CcSEcCtD
Indapamide—CA2—Metabolism—ENO2—bone cancer	0.000126	0.00079	CbGpPWpGaD
Indapamide—Rash—Epirubicin—bone cancer	0.000126	0.000587	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—bone cancer	0.000126	0.000586	CcSEcCtD
Indapamide—Headache—Epirubicin—bone cancer	0.000125	0.000583	CcSEcCtD
Indapamide—CA4—Metabolism—DHFR—bone cancer	0.000122	0.000764	CbGpPWpGaD
Indapamide—Dizziness—Doxorubicin—bone cancer	0.000122	0.00057	CcSEcCtD
Indapamide—CA7—Metabolism—GSTP1—bone cancer	0.00012	0.00075	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTP1—bone cancer	0.00012	0.00075	CbGpPWpGaD
Indapamide—Nausea—Epirubicin—bone cancer	0.000119	0.000553	CcSEcCtD
Indapamide—Vomiting—Doxorubicin—bone cancer	0.000117	0.000548	CcSEcCtD
Indapamide—CA2—Metabolism—DHFR—bone cancer	0.000117	0.000733	CbGpPWpGaD
Indapamide—Rash—Doxorubicin—bone cancer	0.000116	0.000543	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—bone cancer	0.000116	0.000543	CcSEcCtD
Indapamide—Headache—Doxorubicin—bone cancer	0.000116	0.00054	CcSEcCtD
Indapamide—CA4—Metabolism—GNA11—bone cancer	0.000114	0.000714	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTP1—bone cancer	0.000111	0.000695	CbGpPWpGaD
Indapamide—Nausea—Doxorubicin—bone cancer	0.00011	0.000512	CcSEcCtD
Indapamide—CA2—Metabolism—GNA11—bone cancer	0.00011	0.000685	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	0.000109	0.00068	CbGpPWpGaD
Indapamide—CA9—Metabolism—ENO2—bone cancer	0.000106	0.000666	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP3A4—bone cancer	0.000104	0.000648	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP3A4—bone cancer	9.93e-05	0.000621	CbGpPWpGaD
Indapamide—CA9—Metabolism—DHFR—bone cancer	9.88e-05	0.000618	CbGpPWpGaD
Indapamide—CA9—Metabolism—GNA11—bone cancer	9.23e-05	0.000577	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—bone cancer	9.16e-05	0.000573	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—bone cancer	8.86e-05	0.000554	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—bone cancer	8.49e-05	0.000531	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP3A4—bone cancer	8.37e-05	0.000523	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—bone cancer	7.16e-05	0.000448	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—bone cancer	7.05e-05	0.000441	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	6.95e-05	0.000435	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—bone cancer	6.65e-05	0.000416	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—bone cancer	6.21e-05	0.000388	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—bone cancer	6.21e-05	0.000388	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—bone cancer	5.75e-05	0.00036	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NDUFA12—bone cancer	4.94e-05	0.000309	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—bone cancer	4.59e-05	0.000287	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—bone cancer	4.4e-05	0.000275	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NT5C3A—bone cancer	4.09e-05	0.000256	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—bone cancer	3.71e-05	0.000232	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ENO2—bone cancer	1.79e-05	0.000112	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—DHFR—bone cancer	1.66e-05	0.000104	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GNA11—bone cancer	1.55e-05	9.72e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—bone cancer	1.2e-05	7.54e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—bone cancer	6.24e-06	3.9e-05	CbGpPWpGaD
